Skip to main content
Clinical Trials/NL-OMON35993
NL-OMON35993
Completed
Phase 4

A randomised clinical trial on the effectiveness of Emla and Rapydan for prevention of vena punction-induced pain in children. - Pain perception after vena punction.

Isala Klinieken0 sites200 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Pijnbeleving
Sponsor
Isala Klinieken
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Isala Klinieken

Eligibility Criteria

Inclusion Criteria

  • Age 3 \- 18

Exclusion Criteria

  • Allergy for the contents of the plaster

Outcomes

Primary Outcomes

Not specified

Similar Trials